Sign In

Shehnaaz Suliman

Senior Vice President Corporate Development and Strategy at Theravance Biopharma US, Inc.

Professional Background

Shehnaaz Suliman is a distinguished strategic life sciences leader who has spent numerous years cultivating her expertise in business development, early drug development, and corporate strategy within the life sciences sector. With an impressive track record of delivering results, Shehnaaz has effectively driven initiatives that encapsulate pipeline and portfolio planning as well as commercial strategy. Her tenure in the industry is marked by her ability to lead high-performing teams that consistently surpass their goals and achieve their deliverables. Furthermore, Shehnaaz has proven adept at collaborating with Senior Executives and Boards while also being accountable to investors, highlighting her robust leadership abilities and strategic vision.

Throughout her career, Shehnaaz has held several influential positions, which include her role as the Senior Vice President of Corporate Development and Strategy at Theravance Biopharma US, Inc., a major player in the biotech space. She has also enriched her experience as Vice President and Global Head of Immunology, Infectious Diseases, and Specialty Care at Roche Partnering. Her strategic mindset is evident in her previous roles at Genentech, Gilead Sciences, and Lehman Brothers, paving her path as a pivotal force in healthcare investment banking and scientific research management.

Education and Achievements

Shehnaaz Suliman possesses a robust educational background that forms the foundation of her successful career. She holds a Doctor of Medicine (MD) degree from the prestigious University of Cape Town, where she honed her medical knowledge and clinical expertise. In addition to her medical training, she further expanded her business acumen by earning a Master of Business Administration (MBA) from the Saïd Business School at the University of Oxford, one of the most esteemed institutions in the world. Moreover, her time at the University of Oxford has equipped her with the analytical and leadership skills necessary to navigate complex business environments successfully.

Throughout her career, Shehnaaz's commitment to excellence and impactful leadership has been recognized through her involvement in multiple high-profile organizations within the life sciences and biotechnology sectors. Notably, she has served as a Board Member at 10X Genomics, where she has contributed strategic insights to drive innovation in biological research technologies. Additionally, she has previously held board positions at Ultragenyx Pharmaceutical Inc. and Parvus Therapeutics Inc., providing valuable governance experience in the pharmaceutical landscape.

Notable Achievements

Some of Shehnaaz's most significant achievements include overseeing portfolios that have resulted in advanced drug development initiatives and value creation for shareholders. Her role as Senior Vice President at Theravance Biopharma allowed her to spearhead transformative strategies that aligned with investor expectations and market demands. Her leadership qualities were also pivotal in her role at Roche, where she was instrumental in leading projects that bridged various therapeutic areas and drove synergies within the organization.

In addition to her corporate success, Shehnaaz's dedication to healthcare extends to her clinical experience. As a former Clinical Resident at the Ernest Oppenheimer Hospital and a Senior Clinical House Officer at Oxford Radcliffe Hospitals NHS Trust, she garnered firsthand experience in patient care and acute medical scenarios. This dual perspective of medical knowledge along with business insight provides Shehnaaz with a unique advantage in the life sciences sector, allowing her to approach challenges with a well-rounded perspective.

Career Highlights

  • Senior Vice President of Corporate Development and Strategy at Theravance Biopharma US, Inc.
  • Vice President and Global Head, Immunology, Infectious Diseases and Specialty Care at Roche Partnering.
  • Group Leader, Portfolio Management and Operations at Genentech.
  • Significant roles at Gilead Sciences and Lehman Brothers, focusing on corporate development and healthcare investment banking.

Conclusion

Shehnaaz Suliman's professional journey is a testament to her dedication and resolute drive within the life sciences landscape. Her skill set uniquely positions her for continued success, as she embraces opportunities that align with her mission of advancing healthcare through strategic innovation and effective leadership.

Related Questions

How did Shehnaaz Suliman develop her expertise in corporate strategy within the life sciences industry?
What are some of the key initiatives led by Shehnaaz Suliman that contributed to her role at Theravance Biopharma US, Inc.?
How has Shehnaaz Suliman's medical training influenced her strategic decisions in business development?
In what ways has Shehnaaz Suliman contributed to the success of the organizations she has served on boards, such as 10X Genomics?
What challenges did Shehnaaz Suliman face while transitioning from clinical roles to corporate leadership positions in the biotech sector?
S
Add to my network

Location

San Francisco Bay Area